Gero
Founded 2018 Β· 137 employees on LinkedIn Β· 1 known investors
Gero is a biotech company applying AI, data science, and physics-based models of human health to discover drug targets and therapies for aging and age-related chronic diseases. It develops a therapeutic pipeline using longitudinal health data, statistical genetics, and multi-omics.
Founders & leadership
Gero was founded in 2018 by Peter Fedichev and Max.
Investors Β· 1
Competitors Β· 3
by search overlapSoundCloud4 shared keywordsAudio distribution and music-sharing platform for artists and creators.
Genius4 shared keywordsGenius is a crowdsourced music encyclopedia where a community of contributors annotates and discusses song lyrics, artist information, and music culture across all genres. The platform serves artists, creatives, and music fans who want to explore and share deeper context about music and its creators.
Lifespan3 shared keywordsLifespan.io publishes news, research roundups, and advocacy content focused on longevity and rejuvenation therapies aimed at extending healthy lifespan. It covers developments across research, treatment, and policy related to aging.
Companies competing with Gero for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Gero do?
- Gero is a biotech company applying AI, data science, and physics-based models of human health to discover drug targets and therapies for aging and age-related chronic diseases. It develops a therapeutic pipeline using longitudinal health data, statistical genetics, and multi-omics.
- Who founded Gero?
- Gero was founded by Peter Fedichev, Max in 2018.
- Who are Gero's investors?
- Gero's investors include Melnichek Investments.